Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
about
Mutation of SOD1 in ALS: a gain of a loss of functionMisfolded CuZnSOD and amyotrophic lateral sclerosisSmall GSK-3 Inhibitor Shows Efficacy in a Motor Neuron Disease Murine Model Modulating AutophagyExendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosisThe legs at odd angles (Loa) mutation in cytoplasmic dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron disease.A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis.Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis.Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis.Colocalization of 14-3-3 proteins with SOD1 in Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis cases and the animal modelDifferential gene expression in the axotomized facial motor nucleus of presymptomatic SOD1 miceFocal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).Molecular biological approaches to neurological disorders including knockout and transgenic mouse models.New insight into CCN3 interactions--nuclear CCN3 : fact or fantasy?Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis.Gender-Specific Mechanism of Synaptic Impairment and Its Prevention by GCSF in a Mouse Model of ALS.Misfolded proteins, endoplasmic reticulum stress and neurodegeneration.Role of zinc in ALS.UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis.Delayed functional recovery in presymptomatic mSOD1(G93A) mice following facial nerve crush axotomy.Species-dependent neuropathology in transgenic SOD1 pigs.Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?An Ultra-High Field Strength MR Image-Guided Robotic Needle Delivery System for In-Bore Small Animal Interventions.Potentiation of arsenic neurotoxicity by folate deprivation: protective role of S-adenosyl methionine.Optimal methods to characterize the G93A mouse model of ALS.Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis.SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation.Folate deficiency and homocysteine induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accumulation.Glyoxal inactivates glutamate transporter-1 in cultured rat astrocytes.An overview of DNA repair in amyotrophic lateral sclerosis
P2860
Q24305971-D84713F5-6123-4F04-8C10-17F421D83C78Q24683677-9D5BCF02-8F83-4641-B541-D5F2FF994C2FQ27322519-6C31DE32-49D3-40C4-84FB-9019B1F27DE7Q28481242-59ED3AB5-D5BE-4231-98F3-DD3D656D6A08Q30435889-A0AE0373-AD72-4C22-BD0A-6971E775F521Q30473769-8B1AD4AA-163F-408F-9C6C-579AD36DE0F0Q33703773-0D4ACBDF-1121-488C-82AC-EB0395D9E68FQ33714159-576E377B-BEC5-4659-8AC2-A2D8044418FFQ33742729-01DCA950-B093-4C59-A40B-0DE04A693FDBQ33927182-7D8CD0E7-7537-49DC-AE4E-4BEEE3D35B71Q33975101-D8319536-1A87-492F-9582-21EBA163F48FQ34010341-5D3C23FA-60BE-4370-B146-E08EF59E5BC8Q35058868-0F313B6F-F1A4-4E83-86CD-4DC6938490AAQ35065958-C1606118-BF30-404D-AC09-62DF16241DCFQ35594377-57F4BEFA-3344-4E36-A3B3-24912D3E715AQ35613992-B95D9834-6804-4E73-9F05-0FED6F741839Q35941821-EDF87B3D-FE9F-40C2-8DE9-63917EEDF438Q36835575-7A8CD9A7-3C2E-4373-98BD-9F7E9A9C15AAQ37478060-374E3196-6A92-4FE5-AFCF-664781AA2355Q37659117-A0904F3D-2666-434F-9D82-A85FE70B8E50Q37684257-37A02996-941E-4F16-99B0-72CA97DD2C89Q38265205-23CCB90A-0431-457F-86DB-9BF81859D26EQ38636338-07328000-7F34-4905-8B5A-D97915A3E08FQ40011614-C8EA8D1A-642D-4620-AD2F-C6881DA65BDDQ40403362-394C9F82-527F-4C86-829D-50E1CA3E76DFQ42940298-F57A7613-D6B0-4503-AE89-89D9C97926B7Q44258560-849291EC-2F5E-4041-9006-CA82E3CA7E93Q44810798-3E9795EB-A300-4534-B4D9-2F103450D690Q46431606-E7FFD744-BF45-4BF5-9D7F-25F8877B9D78Q58694417-4A78DBDC-75FE-4E42-B0E5-FD2C5E6E31E7
P2860
Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Transgenic mouse model for fam ...... peroxide dismutase-1 mutation.
@ast
Transgenic mouse model for fam ...... peroxide dismutase-1 mutation.
@en
Transgenic mouse model for fam ...... peroxide dismutase-1 mutation.
@nl
type
label
Transgenic mouse model for fam ...... peroxide dismutase-1 mutation.
@ast
Transgenic mouse model for fam ...... peroxide dismutase-1 mutation.
@en
Transgenic mouse model for fam ...... peroxide dismutase-1 mutation.
@nl
prefLabel
Transgenic mouse model for fam ...... peroxide dismutase-1 mutation.
@ast
Transgenic mouse model for fam ...... peroxide dismutase-1 mutation.
@en
Transgenic mouse model for fam ...... peroxide dismutase-1 mutation.
@nl
P2860
P1433
P1476
Transgenic mouse model for fam ...... peroxide dismutase-1 mutation.
@en
P2093
P2860
P356
10.1046/J.1440-1789.2001.00361.X
P577
2001-03-01T00:00:00Z